Crescent Biopharma, Inc.
CBIO
$13.41
$0.322.45%
NASDAQ
| 09/30/2025 | |||||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -12.70% | ||||
| Total Receivables | -- | ||||
| Inventory | -- | ||||
| Prepaid Expenses | -17.95% | ||||
| Finance Division Loans and Leases Current | -- | ||||
| Total Finance Division Other Current Assets | -- | ||||
| Other Current Assets | -- | ||||
| Total Current Assets | -12.75% | ||||
|
|
|||||
| Total Current Assets | -12.75% | ||||
| Net Property, Plant & Equipment | 30.33% | ||||
| Long-term Investments | -- | ||||
| Goodwill | -- | ||||
| Total Other Intangibles | -- | ||||
| Finance Div Loans & Leases LT | -- | ||||
| Total Finance Div Other LT Assets | -- | ||||
| Total Other Assets | -3.27% | ||||
| Total Assets | -12.17% | ||||
|
|
|||||
| Total Accounts Payable | 55.40% | ||||
| Total Accrued Expenses | 19.13% | ||||
| Short-term Debt | -- | ||||
| Current Portion of Long-Term Debt/Capital Leases | -- | ||||
| Finance Division Debt Current | 97.63% | ||||
| Total Finance Division Other Current Liabilities | -0.38% | ||||
| Total Other Current Liabilities | -0.38% | ||||
| Total Current Liabilities | 21.25% | ||||
|
|
|||||
| Total Current Liabilities | 21.25% | ||||
| Long-Term Debt | -- | ||||
| Short-term Debt | -- | ||||
| Capital Leases | -7.61% | ||||
| Finance Division Debt Non Current | -- | ||||
| Total Finance Division Other Non Current Liabilities | -- | ||||
| Total Other Liabilities | -- | ||||
| Total Liabilities | 18.97% | ||||
|
|
|||||
| Common Stock & APIC | 1.05% | ||||
| Retained Earnings | -44.90% | ||||
| Treasury Stock & Other | -- | ||||
| Total Common Equity | -16.72% | ||||
|
|
|||||
| Preferred Stock Redeemable | -- | ||||
| Preferred Stock Non Redeemable | -- | ||||
| Preferred Stock Convertible | 0.00% | ||||
| Preferred Stock, Others | -- | ||||
| Total Preferred Equity | 0.00% | ||||
|
|
|||||
| Total Common Equity | -16.72% | ||||
| Total Preferred Equity | 0.00% | ||||
| Total Minority Interest | -- | ||||
| Total Equity | -16.24% | ||||
|
|
|||||